Recent Finacing
Recent Raise
Eikonoklastes is a preclinical biopharmaceutical developing L-ICON3 tissue-factor-targeted immune conjugates that engage the immune system to selectively kill tumor cells, diseased neovasculature, and tumor stem cells in TNBC.
